Search by Drug Name or NDC
NDC 00078-0729-15 Betoptic S 2.8 mg/mL Details
Betoptic S 2.8 mg/mL
Betoptic S is a OPHTHALMIC SUSPENSION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is BETAXOLOL HYDROCHLORIDE.
MedlinePlus Drug Summary
Ophthalmic betaxolol is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Betaxolol is in a class of medications called beta blockers. It works by decreasing the pressure in the eye.
Related Packages: 00078-0729-15Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Betaxolol Ophthalmic
Product Information
| NDC | 00078-0729 |
|---|---|
| Product ID | 0078-0729_44291b13-d51f-41cc-9395-0c8ab6432ec6 |
| Associated GPIs | |
| GCN Sequence Number | 013721 |
| GCN Sequence Number Description | betaxolol HCl DROPS SUSP 0.25 % OPHTHALMIC |
| HIC3 | Q6G |
| HIC3 Description | MIOTICS AND OTHER INTRAOCULAR PRESSURE REDUCERS |
| GCN | 33211 |
| HICL Sequence Number | 005168 |
| HICL Sequence Number Description | BETAXOLOL HCL |
| Brand/Generic | Brand |
| Proprietary Name | Betoptic S |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | betaxolol hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 2.8 |
| Active Ingredient Units | mg/mL |
| Substance Name | BETAXOLOL HYDROCHLORIDE |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Pharmaceutical Class | Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA019845 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00078-0729-15 (00078072915)
| NDC Package Code | 0078-0729-15 |
|---|---|
| Billing NDC | 00078072915 |
| Package | 1 BOTTLE in 1 CARTON (0078-0729-15) / 15 mL in 1 BOTTLE |
| Marketing Start Date | 2022-08-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |